Andreas Pinter

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Uğur Şahin, Petra Oehm, Evelyna Derhovanessian et al. · Nature · 2020 · 961 citations

Checkpoint-inhibitor-treated Melanoma, Melanoma, Immunology +5

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

Diamant Thaçi, Andrew Blauvelt, Kristian Reich et al. · Journal of the American Academy of Dermatology · 2015 · 537 citations · Full text

Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity

Christos C. Zouboulis, Thrasyvoulos Tzellos, Gregor B. E. Jemec et al. · British Journal of Dermatology · 2017 · 430 citations · Full text

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

Andrew Blauvelt, Kristian Reich, Tsen‐Fang Tsai et al. · Journal of the American Academy of Dermatology · 2016 · 301 citations

Inflammation, Immunology, Clear Study +6

Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus

Jonathan I. Silverberg, Andreas Pinter, Grażyna Pulka et al. · Journal of Allergy and Clinical Immunology · 2019 · 262 citations · Full text